Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Drosophila melanogaster wikipedia , lookup
Common cold wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
DNA vaccination wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Hepatitis B wikipedia , lookup
Molecular mimicry wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
“Bad Roommate!” 3A Protein: An Inhibitor of ER to Golgi Traffic Valders High School SMART Team: Grace L. Ebert, Nicole C. Maala, Joe P. Nagel, Paige N. Neumeyer, Stacie L. Pearson, Gavin X. Schneider, Luke J. Schuh, Kayla N. Walsh, Emily N. Weyker, Alyssa L. Yindra Instructor: Mr. Joseph S. Kinscher Mentor: William T. Jackson, Ph. D., Medical College of Wisconsin 2010-2011 Valders SMART Team Abstract: Acute respiratory illnesses (colds), hepatitis, poliomyelitis, and livestock diseases are caused by members of the viral family Picornaviridae. The common cold is the most prevalent infectious disease in humans and results in major economic impact through loss of productivity and strain on healthcare systems. 3A is a membrane protein produced by these viruses that is necessary for forming viral replication complexes. 3A is an attractive target in strategies to combat these diseases. Normally, cells communicate using the secretory pathway. Proteins from the endoplasmic reticulum (ER) enter the Golgi apparatus where they are processed and packaged into vesicles for secretion. When cells are infected by viruses, the cells produce cytokines and display viral peptides on major histocompatibility complex molecules to induce an immune response. Picornovirus 3A inhibits the host cell immune response by interrupting this communication pathway. 3A inhibits cellular secretion and promotes the remodeling of the endoplasmic reticulum membranes into replication complexes for viral RNA synthesis. This is believed to occur through 3A binding to Golgi-specific-brefeldin-factor 1, which inhibits protein transport. Studies have found that some amino acids in the 3A protein have been evolutionarily conserved and therefore may be important to 3A function. Knowing the significance of these amino acids could lead to an attenuated vaccine encoding a mutated form of 3A. 3A Protein Model Model of Wild Type (3A) Picornovirus Infection The Problem: The common cold, hepatitis, and livestock viruses impact health and economic systems globally. In 2011, South Korea experienced a devastating epidemic of hoof-and-mouth disease. More than 2 million animals were culled to prevent the spread of the disease, costing the country 1.4 billion dollars. In humans, the common cold is the most prevalent infectious disease resulting in loss of productivity which is estimated to cost the U.S. economy 25 billion dollars each year. When infected, cells cannot secrete proteins that would allow an immune response to prevent the spread of the disease. The viral protein 3A could be targeted to combat these diseases. The 3A protein is critical for forming viral replication complexes in host cells. Scientists are researching a way to inhibit 3A with the objective of creating drugs to inhibit the protein or a vaccine containing a mutant form of 3A. The Secretory Pathway nucleus Threonine (T14) Virus- wild type Infection ER based on 1ng7.pdb 3A Golgi Fig. 2 Changing the amino acid sequence of viral protein 3A could provide an attenuated vaccine (Fig. 2). The 3A-2 mutant contains a serine insertion between threonine (T14) and serine (S15). This disrupts the ability of the 3A protein to inhibit endoplasmic reticulum (ER) to Golgi complex communication. Vesicles MHCs Weakened Cytokines Immune “Alerts” 3A inhibits cell protein secretion and vesicles will form from the ER membranes. These vesicles will serve as complexes for viral RNA replication. protein Serine (S15) Like a bad roommate trashes an apartment 3A destroys the host cell. The cell lyses, dies, and newly formed viruses are released for further infection. rough ER Model of Mutant (3A-2) Picornovirus Infection Secretory vesicle Virus- mutant White Blood Cell ribosome Control wild type 3A S.S. Choe et al. Virology 337 (2005) 18-29 ER 3A smooth ER Golgi Golgi Fig. 1 Cells communicate with each other using the secretory pathway, in which proteins from the endoplasmic reticulum (ER) enter the Golgi apparatus and are packaged into vesicles for secretion (Fig. 1). Using this pathway, cells produce cytokines and display viral peptides on major histocompatibility complex molecules (MHCs) to induce an immune response. Fig. 3 Secreted alkaline phosphatase (SEAP) is used to measure protein secretion in eukaryotic cells (Fig. 3). The wild type 3A protein reduced cell secretion by 80 percent after 30 minutes. The 3A-2 mutant demonstrates that cell protein secretion is reduced by only 40 percent after 30 minutes and thus could lead to an attenuated vaccine. Infection protein vesicle 3A-2 mutant MHCs Biological Significance: Further research of the Immune “Alerts” Cytokines The 3A-2 mutant is not effective at reducing protein secretion - the infected cell produces cell-signaling protein molecules (i.e. cytokines) to initiate an immune response. MHCs present a fragment of the antigen (virus) to T lymphocytes, while cytokines activate other white blood cells. Both alert the immune system to destroy infected cells - interrupting viral reproduction. 3A protein may lead to the development of drugs targeting 3A or an attenuated vaccine encoding a mutant 3A. This could potentially lead to treatment or prevention of infectious diseases such as the common cold and hoof and mouth disease. References: 1. Belov et al. Cell Cycle. 6:1. 2007, 36-38 2. Choe et al. Virology . 337. 2005, 18-29 A SMART Team project supported by the National Institutes of Health (NIH)-National Center for Research Resources Science Education Partnership Award (NCCR-SEPA). 3. Hancocks, CNN. January 21, 2011 4. Strauss et al. Journal of Molecular Biology. 330. 2003, 225-234